Isracann Biosciences Receives Land Use & Facility Approvals from Israeli Land Authority and Amends Warrants
28. November 2019 00:05 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 28, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier...
CORRECTION: Isracann Biosciences Submits Cannabis Facility Plans to Israeli Land Authority
21. November 2019 00:39 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 21, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, November 21st, 2019 by Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E)...
Isracann Biosciences Submits Cannabis Facility Plans to Israeli Land Authority
21. November 2019 00:01 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier...
Isracann Biosciences Announces OTC Trading Symbol Change to “ISCNF”, Effective November 15, 2019
15. November 2019 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (FRA: A2PT0E) (formerly OTC: ATLED) (OTC: ISCNF) (the “Company”) an Israel-based company focused...
Isracann Biosciences Hires Expert Consultancy LinC to Steer Israeli Cannabis Project
14. November 2019 00:01 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a...
Isracann Biosciences Advances Architectural and Security Plans for Israeli Project
05. November 2019 00:01 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an...
Isracann Biosciences Launches Phase One Facility Development Program in Israel
28. Oktober 2019 00:01 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is...
Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements
16. Oktober 2019 22:08 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is...
Isracann Biosciences Announces Completion of the Acquisition of Isracann Holdings Inc.
11. Oktober 2019 13:42 ET
|
Atlas Blockchain Group Inc.
VANCOUVER, British Columbia, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (fka Atlas Blockchain Group Inc.) (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to...
Atlas Blockchain Announces Conditional Approval of Transaction with Isracann Biosciences Inc.
25. September 2019 21:11 ET
|
Atlas Blockchain Group Inc.
VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) wishes to advise that further to its...